Good morning, folks, and how are you today? Yet another busy day is unfolding here on the Pharmalot corporate campus, where the leaves are blanketing the grounds and the short people are, as always, hustling off to the local schoolhouses for what we hope is an education. As for us, we are busy downing another cup of stimulation, since we are scrambling to keep up with our to-do list. We suspect that you can relate. A treadmill is a treadmill. Meanwhile, here are some tidbits to get you started. Have a smashing time conquering the world and do stay in touch...
Dublin May Block A Tax Break That Drugmakers Like (The Wall Street Journal)
Hospira Readies Launch Of Remicade Biosimilar In Europe (Financial Times)
J&J To Remove Formaldehyde From Baby Shampoo (Bloomberg News)
More Medicare Part D Plans Have Preferred Pharmacy Networks (Drug Channels)
Quintiles Closes A Phase One Unit In India (Outsourcing Pharma)
Zydus Cadila Signs Biologics Pact With Pieris (Pharma Times)
EDITOR'S NOTE: Please check this post for additional stories during the day